Dr. Toufic Assaad Kachaamy, MD

Dr. Kachaamy practices at City of Hope Cancer Center Phoenix in Goodyear, Arizona, part of City of Hope.

Dr. Kachaamy's NPI, 1831174549, was assigned on December 14, 2005. Dr. Kachaamy holds Arizona license 45753.

Dr. Kachaamy's primary practice is City of Hope Cancer Center Phoenix, at 14200 West Celebrate Life Way, Goodyear, AZ 85338 in Maricopa County. The practice phone is (623) 207-3000.

Dr. Kachaamy's primary practice is City of Hope Cancer Center Phoenix in Goodyear, Arizona, part of City of Hope. The medical group on file is City of Hope. Dmand AI also links Dr. Kachaamy to 2 more medical groups and 1 ambulatory surgery center, each named with a free account. Dr. Kachaamy's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kachaamy practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kachaamy's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Kachaamy's licenses on file in 2 states: Arizona and Virginia.

CMS data shows 345 Medicare services from Dr. Kachaamy across 7 procedure codes in 2024, for 196 Medicare patients. Medicare paid $27,155 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 196 Medicare patients who saw Dr. Kachaamy in 2024. The largest group is 65 to 74, with 116 patients. 72% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kachaamy's median patient age at 71, with 56% women.

In 2024, Dr. Kachaamy wrote 226 Medicare Part D claims for 100 patients. 88% of them were for generic drugs. CMS names the drug for 130 of them, across 4 drugs with 11 or more claims each, at $1,690 in total drug cost. In 2023, CMS named 83 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Kachaamy for performance year 2024, reported as part of a group. Dr. Kachaamy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kachaamy as offering telehealth. CMS counts 219 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Kachaamy, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 24 papers to Dr. Kachaamy, published from 2011 to 2023. 2014 was the busiest year, with 4. The most frequent topics are Esophageal Neoplasms, Palliative Care and Adenocarcinoma. Dr. Kachaamy has published most often in Gastrointest Endosc. Dr. Kachaamy's most frequent co-authors are Rahul Pannala, MD, Pankaj G. Vashi, MD and Sonmoon Mohapatra, MD.

Dmand AI links Dr. Kachaamy to 1 clinical trial. Conditions studied include Esophageal Neoplasms and Esophageal Diseases.

CMS Open Payments shows 353 general payments to Dr. Kachaamy from 32 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 69% of the total. Steris Corporation paid the most, $77,360.